Document 6xaEny149Qo09Qk9o3r9mg3m

3M Examples of corporate leadership From: [REDACTED] @defra.gov.uk Sent: 30 June 2023 15:34 To: [REDACTED]@mmm.com Cc: [REDACTED] [redacted]@defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk [REDACTED]@defra.gov.uk Subject: Examples of corporate leadership Dear [REDACTED] Thank you for engaging with the Chemicals Stakeholder Forum (CSF) PFAS Working Group. I hope you don't mind my taking the liberty of reaching out and connecting you with my DEFRA International chemicals colleagues [REDACTED] who are leading on the international `Beyond 2020 framework' for chemicals. My colleagues are interested in identifying examples of corporate leadership (e.g. moving away from PFAS) that, potentially, the Minister might wish to mention in a speech - and to understand if your companies are considering making any announcements / statements around your corporate leadership on PFAS in the build up to the Beyond 2020 international event (scheduled for Sept 2023). Would you be willing to meet with my colleague [REDACTED], copied in, to discuss? Many thanks in advance for your time in considering. Regards [REDACTED] From: [REDACTED] @defra.gov.uk Sent: 06 July 2023 16:33 To: [REDACTED] @defra.gov.uk [REDACTED]@mmm.com Cc: [REDACTED] @defra.gov.uk; [REDACTED] @defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED] @defra.gov.uk' [REDACTED] @defra.gov.uk Subject: [EXTERNAL] RE: Examples of corporate leadership Hi [REDACTED] Thank you [REDACTED]for e-introducing us. Our team in Defra work on the Beyond 2020 Framework on international chemicals management and the upcoming negotiations at Fifth session of the International Conference for Chemicals Management (ICCM5) being held in September 2023 in Germany. This is a UN led, multistakeholder and multi-sectoral process with both industry and NGO engagement. `We are keen to engage with you in advance of ICCM5, in order to help identify examples of where businesses in the UK are promoting best practice in safe use and design of chemicals and pesticides; and investing in innovations advancing green and sustainable chemistry and cleaner production. ` I'd be grateful if we could set up a meeting to discuss. Please let me know when would be convenient for you, or who best to contact to arrange a time. We would also be happy to share further details and a suggested agenda ahead of the meeting. Kind regards, [REDACTED] From: [REDACTED]@mmm.com Sent: To: [REDACTED] @defra.gov.uk; [REDACTED]@defra.gov.uk CC: [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk;[REDACTED]@def ra.gov.uk Subject: RE: Examples of corporate leadership Hello [REDACTED] Thank you for the invitation, but I (and [REDACTED]) will have to decline on this occasion. Kind Regards, [REDACTED] Meeting with 3M - June 17th From: [REDACTED]@mmm.com Sent: Monday 20 June 2022 11:11 To: [REDACTED]@defra.gov.uk Cc: [REDACTED]@mmm.com Subject: Meeting with 3M - June 17th Hi [REDACTED] Many thanks for your time on Friday - really appreciate the high-level update of Defra's thinking on PFAS. Please find attached the RMOA on fluoropolymers from Plastics Europe, as promised. We are still checking with [REDACTED] whether we can share their decision tree, and also checking with [REDACTED] whether we can share the new SEA report......but will hopefully come back with those documents when we've heard back. Do please keep us in the loop as your thinking develops and certainly interested in any stakeholder discussions that take place. Many thanks [REDACTED] From: [REDACTED]@mmm.com Sent: 27 June 2022 16:00 To: [REDACTED]@mmm.com; [REDACTED]@defra.gov.uk Subject: RE: Meeting with 3M - June 17th Dear [REDACTED] Following up on our meeting and as mentioned by [REDACTED] please find attached the decision tree on PFAS (as a proposal on how to regulate PFAS), as well as a recent socio-economic analysis for fluoropolymers. Many thanks again for the good discussion and please let us know if you have any further questions. Best regards, [REDACTED] From: [REDACTED]@defra.gov.uk Sent: 30 June 2022 11:00 To: [REDACTED]@mmm.com; [REDACTED]@mmm.com Cc: [REDACTED]@defra.gov.uk Subject: [EXTERNAL] RE: Meeting with 3M - June 17th Dear [REDACTED], [REDACTED] Many thanks for passing on the documents and for a helpful discussion on PFAS a couple of weeks ago. Just by way of introduction I'm copying in my colleague [REDACTED] who leads to REACH work programme team as you may hear from her or me in due course as we look to engage with stakeholders on next steps after the RMOA. Thanks, [REDACTED] PFAS RMOA From: [REDACTED]@mmm.com Sent: 06 July 2023 13:57 To: [REDACTED]@defra.gov.uk Cc: [REDACTED]@defra.gov.uk Subject: PFAS RMOA Hi [REDACTED] Long-time no speak.....hope all is well? We picked up the Rebecca Pow answer to a PQ on PFAS last week.....ie that the Government have accepted the recommendations of the RMOA. I was just wondering if this had been published anywhere else as it was the first we'd heard of it? Also - what are the next steps as far as engagement with industry are concerned on the implementation and timetabling of the RMOA? Many thanks [REDACTED] From: [REDACTED]@defra.gov.uk Sent: 07 July 2023 16:02 To: [REDACTED]@mmm.com Cc: [REDACTED]@defra.gov.uk, [REDACTED]@defra.gov.uk Subject: [EXTERNAL] RE: PFAS RMOA Hi [REDACTED] Thanks for getting in touch and good to hear from you. The RMOA has been published on HSE's website: UK REACH: Regulatory management option analysis (RMOA) (hse.gov.uk) and plans to take forward the recommendations was also included in Defra's plan for water (Our Integrated Plan for Delivering Clean and Plentiful Water (publishing.service.gov.uk)). Once you have had a chance to look over the RMOA in more detail I would welcome any thoughts/comments you have on it as this will help inform our ongoing policies on PFAS. The publication would have been announced in HSE's REACH eBulletin which you can sign up to here: UK REACH: eBulletin signup (hse.gov.uk) for anything further. We have not set a timetable for implementing but more information will be provided in the publication of the UK REACH work programme soon. Beyond that we will work with HSE and EA on what is required in terms of ongoing stakeholder engagement. As part of this, as a minimum, the UK REACH restriction processes includes public consultation stages and can include calls for evidence to provide stakeholders opportunity to engage. Another way to engage with our chemicals work in Defra is through the Chemicals Stakeholder Forum. (UK Chemicals Stakeholder Forum (UKCSF) - GOV.UK (www.gov.uk)). Please email chemicals@defra.gov.uk if you would like any more information on this group or would be interested in joining the next meeting on 20th July where PFAS is amongst the agenda items for discussion. Hope this is helpful and let me know if any further questions on PFAS policy. Thanks, [REDACTED] From: [REDACTED]@mmm.com Sent on: Tuesday, July 11, 2023 2:31:49 PM To: [REDACTED]@defra.gov.uk CC: [REDACTED]@ defra.gov.uk, [REDACTED]@defra.gov.uk Subject: RE: PFAS RMOA Hi [REDACTED] Many thanks for coming back to me. We are pretty well plugged into the various alerts - but I guess just didn't spot the key bits when they came out! Timing is everything, as they say. We have a 3Mer, my colleague [REDACTED]on the Chemicals Stakeholder forum - so hopefully we are covered on that front. I think, in general, we thought the RMOA was pretty sensible and pragmatic Cheers [REDACTED] AGC Adoption of the EU POP PFOA Delegated Act From: [REDACTED]@agc.com Sent on: Thursday, March 2, 2023 10:32:55 AM To: [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk CC: [REDACTED]@agc.com, [REDACTED]@kreab.com Subject: Adoption of the EU POP PFOA Delegated Act Attachments: EU POP PFOA DA Final.pdf (389.43 KB), EU POP PFOA Annex Final.pdf (269.53 KB) See annex 1 Dear [REDACTED] We would like to inform you that the European Commission adopted the delegated act on POP PFOA (please see attached). Regarding PTFE micropowders, point 4 has been replaced by the following: "4. For the purposes of this entry, Article 4(1), point (b), shall apply to concentrations of PFOA and its salts equal to or below 1 mg/kg (0,0001 % by weight) where they are present in polytetrafluoroethylene (PTFE) micropowders produced by ionising irradiation or by thermal degradation as well as in mixtures and articles for industrial and professional uses containing PTFE micropowders until [OP, please insert the date = 90 days after the date of entry into force of this Regulation]. All emissions of PFOA during the manufacture and use of PTFE micropowders shall be avoided and, if not possible, reduced as far as possible. The limit of 1 mg/kg (0,0001 % by weight) shall apply only to manufacture, placing on the market and use of PFOA and its salts where they are present in PTFE micropowders that are transported or treated for the purpose to reduce the concentration of PFOA and its salts below the limit of 0,025 mg/kg (0,0000025 % by weight)". The European Commission adopted AGCCE's proposed derogation wording, setting a 1ppm UTC level for the manufacture, placing on the market and use of PFOA and its salts present in PTFE micropowders that are transported or treated for the purpose of reducing the concentration level of PFOA and its salts below 25 ppb (final use). The delegated act precises that the treatment of PTFE micropowders qualifies as "use" and the transfer to a different legal entity for treatment as "placing on the market". Note that the derogation for the use of PFOA, its salts and PFOA-related compounds in the manufacture of PTFE and PVDF under point 5 (e) is removed. Next steps:  Entry into force: 20th day following that of its publication to the Official Journal of the European Union Entry into application: 3 months after the date of entry into force With kind regards, [REDACTED] DEFRA'S F-Gas survey participation From: [REDACTED]@agc.com Sent on: Thursday, August 3, 2023 3:25:19 AM To: [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk; CC: [REDACTED]@agc.com; [REDACTED]@agc.com; [REDACTED]@agc.com; [REDACTED]@agc.com; [REDACTED] @agc.com Subject: DEFRA'S F-Gas Review Dear [REDACTED] Thank you very much for your time this morning. It was very useful to understand details of this Fgas revision, timescales and the impact it could have on our operations. It was recognised from this meeting that this policy revision is focusing on the equipment and quota will be tightened to provide maximum environmental benefits. AGC Chemicals Europe ltd (AGCCE, our Thornton-Cleveleys site in UK) uses F-gases as a feedstock in manufacturing and there is no immediate impact on our operation, as feedstock and monomers remain out of scope. We do however import and sell some F-gases from AGC Japan. Those could be affected by the change as the overall quota will reduce and the cost of obtaining quota will increase. If feedstock comes under the review or scope in the future, AGCCE will be very keen to get involved and will be available to discuss. With best wishes, [REDACTED] DEFRA'S F-Gas survey participation From: [REDACTED]@defra.gov.uk Sent: Thursday, July 27, 2023 5:22PM To: [REDACTED]@agc.com CC: [REDACTED]@agc.com; [REDACTED]@agc.com; [REDACTED]@agc.com; [REDACTED]@agc.com; [REDACTED]@defra.gov.uk Subject: RE: DEFRA'S F-Gas survey participation Dear [REDACTED] The 3rd August 8am-9am works for us. Best Regards, [REDACTED] From: [REDACTED]@agc.com Sent: 27 July 2023 16:43 To: [REDACTED]@defra.gov.uk CC: [REDACTED]@agc.com; [REDACTED]@agc.com; [REDACTED]@agc.com; [REDACTED]@agc.com; [REDACTED]@defra.gov.uk Subject: RE: DEFRA'S F-Gas survey participation Dear [REDACTED] Many thanks for getting back to me and providing clarification. We certainly believe teams meeting will be useful. After confirming availabilities of our Sustainability Department, I would like to propose following dates for teams meeting: Tuesday 1st August 11:00 to 13:00 Thursday 3rd August 08:00 to 09:00 Please let me know which date and time is more suitable and if not, we will try and find alternatives. Once confirmed I will send teams invite. Please let me who else from your team I should send invite to. Looking forward to hearing from you. Best regards [REDACTED] From: [REDACTED]@defra.gov.uk Sent: Tuesday, July 25, 2023 11:21 AM To: [REDACTED]@agc.com CC: [REDACTED]@agc.com; [REDACTED]@agc.com; [REDACTED]@agc.com; [REDACTED]@agc.com; [REDACTED] @defra.gov.uk Subject: RE: DEFRA'S F-Gas survey participation Dear [REDACTED] Thank you for getting in touch. We welcome manufacturer participation in this process. Our survey is designed to focus on a subset of equipment containing F-Gases where we believe we need more data to inform our quota calculation. As you appear to be exclusively a chemicals manufacturer I think it may be more helpful to set up a conversation via Teams. If that is suitable for you please let me know your availability and we can arrange a call. Best Regards, [REDACTED] From: [REDACTED] @agc.com Sent: 25 July 2023 10:06 To: [REDACTED]@defra.gov.uk CC: [REDACTED]@agc.com; [REDACTED]@agc.com; [REDACTED] @agc.com Subject: DEFRA'S F-Gas survey participation Dear [REDACTED] I work at [REDACTED]. We were just made aware, through European Partnership for Energy and the Environment that we are members of, that DEFRA is launching an F-gas survey which will have a direct impact on the future F-Gas legislation. We would like to express our interest in participation in this survey. We believe we can provide information to this topic via survey but also available for Teams Meeting. Looking forward to hearing from you. With best wishes, [REDACTED] [EMAIL REDACTED] [EMAIL REDACTED] [EMAIL REDACTED] [EMAIL REDACTED] [EMAIL REDACTED] [EMAIL REDACTED] [EMAIL REDACTED] [EMAIL REDACTED] Response to call for comments From: [REDACTED]@defra.gov.uk Sent: Monday, June 19, 2023 12:48 PM To: [REDACTED]@agc.com Subject: Response to call for comments Dear [REDACTED] Thank you for taking the time to respond to our recent call for comments for the Stockholm Convention on the revised draft Risk Profile for chlorpyrifos and the draft Risk Management Evaluations for MCCPs and long-chain PFCAs. In answer to one of the questions in the call for comments, you indicated that you would like the information provided in your response to be treated confidentially. We are preparing to publish a short summary of responses and as you have requested confidentiality, I can confirm that we will not release your name, your organisation or any of your contact details in the publication. Information contained within responses to consultations and calls for comments may be subject to release to the public or other parties in accordance with the access to information law (primarily the Environmental Information Regulations 2004 (EIRs), the Freedom of Information Act 2000 (FOIA) and the Data Protection Act 2018 (DPA)). Defra has obligations, mainly under the EIRs, FOIA and DPA, to disclose information to particular recipients or to the public in certain circumstances. If at some point we receive a request for the information that you have provided in your response, we would take full account of your reasons for requesting confidentiality of your response, but we would be required to make an assessment on which parts of your response we would need to release subject to any exemptions or exceptions that may apply in the FOIA/EIRs. In order for us to balance these obligations for disclosure against obligations for confidentiality, it would be really helpful if you could send some further details explaining your reasons for requesting confidentiality for parts of your response. In doing so, please could you also specify which sections of your response you would like treated as confidential. If possible, please would you be able to provide the further information to us by next Monday 26th June. I have attached a copy of your response for ease of access. Please do not hesitate to get in contact if you have any questions about this. Regards, [REDACTED] From: [REDACTED]@agc.com; [REDACTED] @agc.com Sent: 19 June 2023 14:19 To: [REDACTED]@defra.gov.uk Subject: RE: Response to call for comments Dear [REDACTED] Thank you for your email. I note your target date of 26th June and expect to be able to send you a detailed response by then. With kind regards, [REDACTED] From: [REDACTED]@defra.gov.uk Sent: Monday, June 19, 2023 2:28 PM To: [REDACTED]@agc.com Subject: RE: Response to call for comments Dear [REDACTED] With many thanks for responding so quickly and for agreeing to a response by the 26th, it is really appreciated. With kind regards, [REDACTED] From: [REDACTED]@agc.com Sent: 26 June 2023 12:34 To: [REDACTED]@defra.gov.uk Cc: [REDACTED]@agc.com Subject: RE: Response to call for comments Hi [REDACTED] Please find attached a revised contribution from AGC Chemicals Europe, Ltd. I can confirm that the attached contribution contains no confidential information. See annex 2. With kind regards, [REDACTED] From: [REDACTED] @defra.gov.uk Sent: Friday, March 3, 2023 2:44:51 PM To: [REDACTED]@agc.com ;[REDACTED] @defra.gov.uk Cc: [REDACTED]@agc.com Subject: Adoption of the EU POP PFOA Delegated Act Hello [REDACTED] Thank you very much for your recent correspondence and for sharing the below update. I'm pleased to say that Defra's consultation on potential amendments to the Persistent Organic Pollutants Regulation is now live and can be found here: Consultation on potential amendments to the Persistent Organic Pollutants (POPs) Regulation - Defra - Citizen Space Thank you again for your engagement in the run up to its launch. The consultation will be open for 8 weeks, closing on 27 April. You'll see that there are a number of proposals and a great deal of information included in the consultation, but respondents are not expected to answer each section, only those most relevant to them. You'll see in the contents that there is a specific section for PFOA in PTFE micropowders and that the lead proposal aligns with the position set out in our correspondence to you following the review of PFOA exemptions carried out last year. Do let me or [REDACTED] know if you have any questions. Kind regards, [REDACTED] From: [REDACTED]@agc.com Sent: Friday, March 3, 2023 2:46:46 PM To: [REDACTED]@defra.gov.uk; [REDACTED] @defra.gov.uk Cc: [REDACTED]@agc.com Subject: RE: Adoption of the EU POP PFOA Delegated Act Dear [REDACTED], Thank you for the information, we will review and comment if appropriate. With kind regards, [REDACTED] UK PFOA POP review - update on EU PFOA POP From: [REDACTED]@agc.com Sent: 28 November 2022 17:06 To: [REDACTED]@defra.gov.uk Cc: [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk Subject: UK PFOA POP review - update on EU PFOA POP Dear [REDACTED] I would just like to give you a brief update on the EU's approach to the PFOA POP revision. Please find attached the text that was discussed at the EU-POP meeting held earlier in November. Our analysis is that the derogation wording under point 4 covers AGC's needs, including a threshold at 1 ppm for the manufacture, placing on the market and use of PFOA and its salts where present in PTFE micropowders that are transported or treated for the purpose of reducing the concentration level of PFOA and its salts below 25 ppb. The wording proposed by the European Commission is in line with DEFRA's, and will allow the continuation of the production of PTFE micropowders by irradiation and thermal degradation by AGCCE in the UK and the EU. We are expecting the entry into application of the delegated act (90 days after entry into force of the delegated act) to be around May 2023. We look forward to an update on the UK's progress with the PFOA POP regulation once you are able to share some new information. With kind regards, [REDACTED] From: [REDACTED]@defra.gov.uk; Sent: 11 January 2023 10:49 To: [REDACTED]@agc.com; [REDACTED]@agc.com Subject: RE: UK PFOA POP review - update on EU PFOA POP Hi [REDACTED], Many thanks for this update and for sharing the text discussed at the EU-POP meeting held in November. I'm emailing to provide you with an update on our work to make the necessary legislative changes in the Retained EU POPs Regulations and to check what information we can use in our planned consultation. We are planning to consult on a range of POPs exemptions in the first half of 2023. As part of this process, we are gathering existing evidence that we have that can inform our assessment of potential impacts resulting from the exemptions. This evidence will be published alongside the consultation documents. In our prior engagement with AGCCE(UK) on the statutory review of point 4 of the PFOA entry in Annex I of the Retained EU POPs Regulations, you shared information with us detailing why the derogation was required. Are we able to use the information you provided us for the PFOA review for the purpose of the consultation evidence? We are able to anonymise you as a company as the EU does with their consultation documents. We would not use or share any commercially sensitive information that was marked as such and password protected. Best, [REDACTED] From: [REDACTED]@defra.gov.uk Sent: 26 January 2023 17:16 To: [REDACTED]@agc.com; [REDACTED]@agc.com Subject: RE: UK PFOA POP review - update on EU PFOA POP*** External email: Please be cautious when opening attachments or clicking links. *** Hi [REDACTED] No problem and thanks for considering my request. To answer your questions in turn: We are currently in the process of preparing a public consultation on proposed changes to the GB POPs Regulation. We anticipate that this consultation will be open for public response in the spring, and that any legislative changes made will be in force no earlier than November 2023. The point 4 exemption you provided evidence on last year is only one element of several legislative changes being proposed in this consultation. On the point 4 exemption specifically, the information you provided in the review last year was really valuable and helped inform the evidence and context for this consultation. The letter you received on 26 September 2022 outlines the proposed changes to point 4. It also makes reference to the fact that this change will need to be made through legislation. As we are making proposals for legislative changes to the GB POPs regulation, we are opting to include these in our formal public consultation to supplement the statutory review we completed last year. We are able to provide a draft of any evidence or copy in the consultation which relates to information provided by AGCCE(UK). We are unable to say exactly when this would be, but would be in the next couple of months whilst we are preparing the consultation. If you were able to provide a version of AGCCE(UK)'s input to the review with any confidential information omitted, this would be hugely helpful. Thank you. Would it be possible to share this with us by the end of next week? Do let me know if you need any more information on any of the above. Thanks, [REDACTED] From: [REDACTED]@agc.com Sent: 03 February 2023 17:02 To: [REDACTED]@defra.gov.uk; [REDACTED]@agc.com Subject: RE: UK PFOA POP review - update on EU PFOA POP Dear [REDACTED] Please find attached a 2-page non-confidential input from AGCCE. Please let me know if you need to discuss or have any further questions. See annex 3. As a reminder, here is a question/comment from a recent message that I sent to you: Please can you confirm the process after the consultation? For example, does it go for a vote in Parliament or is it agreed by another route? With best wishes, [REDACTED] From: [REDACTED]@defra.gov.uk Sent: 08 February 2023 16:32 To: [REDACTED]@agc.com; [REDACTED]@agc.com Cc: [REDACTED]@defra.gov.uk Subject: RE: UK PFOA POP review - update on EU PFOA POP Hi [REDACTED], Thank you very much for sharing this with us. Regarding your question, once the consultation has competed and the final SI drafted, it will go through an affirmative procedure. This means it will need approval in both the House of Commons and the House of Lords before it enters into force. I am on annual leave from tomorrow until Monday 27th February but I have cc'd my colleague [redacted] should you have any further questions in my absence. Many thanks, [REDACTED] From: [REDACTED]@defra.gov.uk Sent: 24 February 2023 15:13 To: [REDACTED]@agc.com; [REDACTED]@agc.com Cc: [REDACTED]@defra.gov.uk Subject: RE: UK PFOA POP review - update on EU PFOA POP Hello [REDACTED] I hope you're well and thank you so much for your input and engagement on the upcoming consultation so far. We said that if we included any of the information you provided we would check it with you first to confirm you were happy for it to be used. I have copied a paragraph below which we would like to used in the consultation. Please could you confirm if you are happy for this information to be included? If you were able to let me know by the end of business Monday (27th) I would be very grateful. Apologies for the quick turnaround and do let me know if it's not possible. Through industry engagement, Defra is aware of at least one company that manufactures PTFE micropowders in the UK, during which PFOA is unintentionally generated above 0.025 mg/kg in the final stage of the production process. During this process, the PTFE micropowders remain in sealed containers during transport to and from an abatement facility, a gas scrubbing plant, where fluorinated compounds are captured and subsequently disposed of by an external contractor by incineration. The PTFE micropowders product range is a significant portion of the company's manufacturing in the UK. Without the derogation wording, there would be economic consequences for downstream sectors such as plastic and rubber, defensive flares and the coatings industry. Thanks again and do feel free to get in touch with any questions you may have. Kind regards [REDACTED] From: [REDACTED]@agc.com Sent: 24 February 2023 16:06 To: [REDACTED]@defra.gov.uk; [REDACTED]@agc.com Cc: [REDACTED] @defra.gov.uk Subject: RE: UK PFOA POP review - update on EU PFOA POP Dear [REDACTED] Just wanted to acknowledge your request. As it is a short paragraph, I would expect that we can confirm by the end of Monday. With kind regards, [REDACTED] Chemical Industries Association [EMAIL REDACTED] [EMAIL REDACTED] [EMAIL REDACTED] [EMAIL REDACTED] [EMAIL REDACTED] [EMAIL REDACTED] [EMAIL REDACTED] [EMAIL REDCTED] From: [REDACTED]@cia.org.uk Sent: Friday, September 8, 2023 13:46 To: [REDACTED]@defra.gov.uk Cc: [REDACTED]@cia.org.uk Subject: RE: PFAS guide Hi [REDACTED] [REDACTED] CIA continues to work with Cefic in the chemicals management area, and we understand a lot of good work is being done in terms of identifying uses of PFAS and that guidance on waste management of process equipment is under development. As this develops, we'll see what is possible to share. Have a good weekend. Kind regards, [REDACTED] Chemours Defra 2023 F-gas industry survey From: [REDACTED]@defra.gov.uk Sent: Thursday, July 13, 2023 1:48PM Subject: Defra 2023 F-gas industry survey Good afternoon all Thank you again to those who were able to attend the stakeholder event last week, where we provided some updates on the GB F-gas review and talked through our planned survey to help fill some of the gaps in our modelling. Please find attached a copy of the slides presented in the session. See Annex 4. If you would like to participate in the Defra survey please use this link to register an interest in participating. Please feel free to share the above link with any manufacturers who would like to Participate. You will be asked to provide the email address you would like to use for your organisation. Please note this only used to control access. All responses will be confidential and anonymous. If you have any questions on the survey, please get in touch with [REDACTED] Thank you in advance for your time. [REDACTED] GB F-gas review - update and factfinding survey From: [REDACTED]@defra.gov.uk; Sent: Thursday, June 8, 2023 11:55 AM To: [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk Cc: [REDACTED]@ior.org.uk; [REDACTED]@googlemail.com; [REDACTED]@businessedgeltd.co.uk; [REDACTED]@acumenpa.com; [REDACTED]@acumenpa.com; [REDACTED]@agas.com; [REDACTED]@agas.com [REDACTED]@airedale.com; [REDACTED]@airedale.com; [REDACTED]@airedale.com; [REDACTED]@amdea.org.uk; [REDACTED]@appliaeurope.onmicrosoft.com; [REDACTED]@area-eur.be; [REDACTED]@centrogalileo.it; [REDACTED]@arkema.com; [REDACTED]@beama.org.uk; [REDACTED]@beama.org.uk; [REDACTED]@beijerref.co.uk; [REDACTED]@beijerref.co.uk; [REDACTED]@beijerref.co.uk; [REDACTED]@beis.gov.uk; [REDACTED]@theBESA.com; [REDACTED]@theBESA.com; [REDACTED]@theBESA.com; [REDACTED]@boc.com; [REDACTED]@bureauveritas.com; [REDACTED]@uk.bureauveritas.com; [REDACTED]@politicalsolutions.co; [REDACTED]@carrier.com; [REDACTED]@carrier.com; [REDACTED]@carrier.com;[REDACTED]@chemours.com; [REDACTED]@chemours.com; [REDACTED]@chemours.com; [REDACTED]@cityandguilds.com; [REDACTED]@cityandguilds.com; [REDACTED]@cityandguilds.com; [REDACTED]@cladees.com; [REDACTED]@clade-es.com; [REDACTED] @climalife.dehon.com; [REDACTED]@climalife.dehon.com; [REDACTED]@daikinchem.de; [REDACTED]@daikinchem.de; [REDACTED]@daikinchem.de; [REDACTED]@daikineurope.com; [REDACTED]@daikinchem.de; [REDACTED]@daikin.co.uk; [REDACTED]@daikin.co.uk; [REDACTED]@epta-uk.com; [REDACTED]@foster-gamko.com; [REDACTED]@fea.org.uk; [REDACTED]@feta.co.uk; [REDACTED]@feta.co.uk; [REDACTED]@harpintl.com; [REDACTED]@honeywell.com; [REDACTED]@kensaengineering.com; [REDACTED]@kensaengineering.com; [REDACTED]@kensaengineering.com;[REDACTED]@kensaengineering.com; [REDACTED]@klimatherm.co.uk; [REDACTED]@kouraglobal.com; [REDACTED]@mace.mee.com; [REDACTED]@meuk.mee.com; [REDACTED]@meuk.mee.com; [REDACTED]@nationalref.com; [REDACTED]@nationalref.com; [REDACTED]@PACONSULTING.COM; [REDACTED]@paconsulting.com; [REDACTED]@PACONSULTING.COM; [REDACTED]@eu.panasonic.com; [REDACTED]@eu.panasonic.com; [REDACTED]@quidos.co.uk; [REDACTED]@quidos.co.uk; [REDACTED]@sepa.org.uk; [REDACTED]@shecco.com; [REDACTED]@shecco.com; [REDACTED]@shecco.com; [REDACTED]@tecumseh.com; [REDACTED]@tevlimited.com; [REDACTED]@star-ref.co.uk; [REDACTED]@wolseley.co.uk; [REDACTED]@gov.scot; [REDACTED]@gluckmanconsulting.com; [REDACTED] @defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@daikinchem.de; [REDACTED] @defra.gov.uk; [REDACTED]@kensaengineering.com; [REDACTED]@kensaengineering.com; [REDACTED]@kensaengineering.com; [REDACTED]@kensaengineering.com; [REDACTED]@kensaengineering.com; [REDACTED]@quidos.co.uk; [REDACTED]@quidos.co.uk; [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@jehall.co.uk; [REDACTED]@dorin.com; [REDACTED]@kensaengineering.com Subject: GB F-gas review - update and factfinding survey When: 05 July 2023 14:00-15:00 Where: Microsoft Teams Meeting Hi all I realise it has been some time since our last stakeholder event. Over the last few months we have been working to develop policy options, which we plan to go out to consultation on in due course. To support analysis of the policy options we will be launching an industry stakeholder factfinding survey, intended to collect data where we have gaps in information. This is an opportunity for stakeholders to provide direct input into our phasedown modelling. We are planning to hold a session to talk through the survey and to provide an update on the review. If you have any questions in advance of the event, please do not hesitate to get in contact with myself or [REDACTED] Thanks, [REDACTED] Honeywell GB F-Gas review -----Original Appointment----- From: [REDACTED]@defra.gov.uk Sent: Thursday, July 20, 2023 2:03 PM To: [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk Cc: [REDACTED]@abpi.org.uk; [REDACTED]@abpi.org.uk; [REDACTED]@ acumenpa.com; [REDACTED] @ acumenpa.com; [REDACTED]@ acumenpa.com; [REDACTED]@ aptar.com; [REDACTED]@ aptar.com; [REDACTED]@ashmaandlung.org.uk; [REDACTED]@aukblf.org.uk; [REDACTED]@aspirepharma.co.uk; [REDACTED]astrazeneca.com; [REDACTED]@astrazeneca.com; [REDACTED]@ astrazeneca.com; [REDACTED]@boehringeringelheim.com; [REDACTED]@boehringer-ingelheim.com; [REDACTED]@boehringeringelheim.com; [REDACTED]@Chiesi.com; [REDACTED]@daikinchem.de; [REDACTED]@daikinchem.de; [REDACTED]@daikinchem.de; [REDACTED]@daikinchem.de; [REDACTED]@emig.org.uk; [REDACTED]@ fticonsulting.com; [REDACTED]@ fticonsulting.com; [REDACTED]@gsk.com; [REDACTED]@gsk.com; [REDACTED]@gsk.com; [REDACTED]@gsk.com; [REDACTED]@gsk.com; [REDACTED]@honeywell.com; [REDACTED]@honeywell.com; [REDACTED]@honeywell.com; [REDACTED]@faegredrinker.com; [REDACTED]@kindevadd; [REDACTED]@kouraglobal.com; [REDACTED]@sandoz.com; [REDACTED]@recipharm.com; [REDACTED]@recipharm.com; [REDACTED]@scholition.org; @teva.com; [REDACTED]@vectura.com; [REDACTED]@vectura.com; [REDACTED]@vectura.com; [REDACTED]@gluckmanconsulting.com; [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@environmentagency.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@deara-ni.gov.uk; [REDACTED]@gv.wales; [REDACTED]@gov.scot; [REDACTED]@nhs.net; [REDACTED]@nhs.net; [REDACTED]@nhs.net; [REDACTED]@nhs.net; [REDACTED]@nhs.net; [REDACTED]@nhs.net; [REDACTED]@defra.gov.uk; [REDACTED]@gov.scot; [REDACTED]@gov.scot; [REDACTED]@gmail.com; [REDACTED]@imperial.ac.uk; [REDACTED]@imperial.ac.uk; [REDACTED]@nhs.net; [REDACTED]@bfwhospitals.nhs.uk; [REDACTED]@uhl-tr.nhs.uk; [REDACTED]@mhra.gov.uk; [REDACTED]@mhra.gov.uk; [REDACTED]@dhsc.gov.uk; [REDACTED]@uhl-tr.nhs.uk; [REDACTED]@dhsc.gov.uk [REDACTED]@gov.scot; [REDACTED]@gov.scot; [REDACTED]@gov.scot; [REDACTED]@gov.scot; [REDACTED]@boehringer-ingelheim.com; [REDACTED]@nhs.net Subject: GB F-gas review - MDI sector When: 02 August 2023 14:00-15:00 Where: Microsoft Teams Meeting Hi all We are aware it has been some time since our last MDI sector group meeting. Over the last few months, we have been working to develop policy options, which we plan to go out to consultation on in due course. To support further development and analysis of the policy options we are keen to discuss some questions and scenarios to better understand the potential impacts of such measures and to check our assumptions around the timing and progress of transition to alternative propellants and other associated interactions with potential measures. The focus of the discussion will be on the GB MDI market - production and manufacturing. We have extended the invitation to the event to NHS, other government department and related bodies, as well as clinicians, as we understand how complex this sector is and the need for us to ensure measures do not result in unintended consequences for patients. If you have any questions in advance of the event, please do not hesitate to get in contact with myself or [REDACTED] We hope to see you there. [REDACTED] From: [REDACTED]@defra.gov.uk Sent: Friday, August 4, 2023 9:43 AM To: [REDACTED] @defra.gov.uk Cc: [REDACTED]@abpi.org.uk; [REDACTED]@abpi.org.uk; [REDACTED]@ acumenpa.com; [REDACTED] @acumenpa.com; [REDACTED] @ acumenpa.com; [REDACTED] @ aptar.com; [REDACTED] @ aptar.com; [REDACTED] @ashmaandlung.org.uk; [REDACTED] @aukblf.org.uk; [REDACTED] @aspirepharma.co.uk; [REDACTED] astrazeneca.com; [REDACTED] @astrazeneca.com; [REDACTED] @ astrazeneca.com; [REDACTED] @boehringeringelheim.com; [REDACTED] @Chiesi.com; [REDACTED] @daikinchem.de; [REDACTED] @daikinchem.de; [REDACTED] @daikinchem.de; [REDACTED] @daikinchem.de; [REDACTED] @emig.org.uk; [REDACTED] @ fticonsulting.com; [REDACTED] @ fticonsulting.com; [REDACTED] @gsk.com; [REDACTED] @gsk.com; [REDACTED] @gsk.com; [REDACTED] @gsk.com; [REDACTED]@gsk.com;[REDACTED] @honeywell.com; [REDACTED] @honeywell.com;[REDACTED] @honeywell.com; [REDACTED] @faegredrinker.com; [REDACTED] @kindevadd; [REDACTED] @kouraglobal.com; [REDACTED] @sandoz.com; [REDACTED] @recipharm.com; [REDACTED] @recipharm.com; [REDACTED] @scholition.org; [REDACTED] @teva.com; [REDACTED] @vectura.com; [REDACTED] @vectura.com; [REDACTED] @vectura.com; [REDACTED] @gluckmanconsulting.com; [REDACTED] @defra.gov.uk; [REDACTED] @defra.gov.uk; [REDACTED] @environmentagency.gov.uk; [REDACTED] @defra.gov.uk; [REDACTED] @deara-ni.gov.uk; [REDACTED] @gv.wales; [REDACTED] @gov.scot; [REDACTED] @nhs.net;[REDACTED] nhs.net; [REDACTED] @nhs.net; [REDACTED] @nhs.net; [REDACTED] @nhs.net; [REDACTED] @nhs.net; [REDACTED]@defra.gov.uk; [REDACTED] @gov.scot; [REDACTED] @gov.scot; [REDACTED] @gmail.com; [REDACTED] @imperial.ac.uk; [REDACTED] @imperial.ac.uk; [REDACTED] @nhs.net; [REDACTED] @bfwhospitals.nhs.uk; [REDACTED] @uhl-tr.nhs.uk; [REDACTED] @mhra.gov.uk; [REDACTED] @mhra.gov.uk; [REDACTED] @dhsc.gov.uk; [REDACTED] @uhltr.nhs.uk; [REDACTED] @dhsc.gov.uk; [REDACTED] @gov.scot; [REDACTED] @gov.scot; [REDACTED] @gov.scot; [REDACTED] @gov.scot; [REDACTED] @boehringer-ingelheim.com; [REDACTED] @nhs.net Subject: RE: GB F-gas review - MDI sector Good morning Thank you to everyone who was able to attend our stakeholder event on Wednesday. I have attached a copy of the slides presented and we welcome any further feedback, particularly in relation to slide 6. See annex 5. Please do not hesitate to get in contact if you have any questions. Thanks [REDACTED] Honeywell Meeting follow up From: [REDACTED]@Honeywell.com Sent: 21 December 2023 10:52 To: [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk Cc: [REDACTED]@Honeywell.com Subject: Honeywell Meeting follow up Attachments: [REDACTED] Hallo DEFRA team, I am writing to follow-up on our meetings in your offices a few weeks back. Firstly, thank you for the open discussion and exchanges, we really appreciated it. [redacted] We were sorry to have missed meeting you in person. We hope you are now back to full health. We would welcome the chance to meet you in 2024. I attach: [REDACTED] One item we forgot to mention in the meeting was the EU Notification to the WTO of the F-gases Regulation review in November - see attached. We had wanted to make sure you were aware of this and would like to understand if the UK might be considering engaging or responding to the EU on any potentially barriers to trade the UK might see the revised Regulation. For your awareness we are in contact in recent weeks with the US government who are discussing their concerns with the DG Climate Action in the European Commission, and it is looking like they will formally respond to this notification. Our team remains available and willing to connect should you wish again in the near future. We wish the team a restful and relaxing Christmas period. Best regards, [REDACTED] Honeywell meeting request: to talk F-gases review and HFOs From: [REDACTED]@Honeywell.com Sent: Monday, November 13, 2023 2:05 PM To: [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk; [REDACTED]@defra.gov.uk Subject: Honeywell meeting request: to talk F-gases review and HFOs Importance: Low Hallo [REDACTED] and Team, I hope this finds you all well. I am writing to request a meeting with you and the Honeywell business team on the ongoing review of the UK F-gases Regulation. We would be happy to come to your offices in London to do this meeting in person. Honeywell is a global manufacturer and importer of various fluorinated gases to the United Kingdom including hydrofluorocarbons (HFC) and hydrofluoroolefins (HFO) refrigerants and their mixtures (blends), primarily used in refrigeration, heating, ventilation and air conditioning (RHVAC), mobile air conditioning (MAC), thermal management systems (TMS) in electric vehicles (EV), propellants including in medical dose inhalers (MDI) and insulation foams blowing agent applications. [REDACTED] As a company we have a vast experience working alongside end-users across the full range of applications to support them in making their gases choices. We are aware that this is not simply a matter one size fits all approach on alternatives or a drop-in replacement. End-users after careful consideration and evaluation choose solutions which balance regulatory compliance, safety, best efficiency, performance and total cost of ownership. We look forward to hearing back from the team on this invite at your earliest convenience. Best regards, [REDACTED] Koura From: [REDACTED]@kouraglobal.com Sent: Wednesday, August 2, 2023 3:06 PM To: [REDACTED]@defra.gov.uk Subject: RE: GB F-gas & ODS review stakeholder event Hi [REDACTED] Good discussion today - I think you assembled a very knowledgeable team! One other point I didn't touch on during the discussion is that I maintain a massive model of the global MDI business, listing pretty much all the MDI companies, what they make, and how much propellant they use. Whilst certain aspects are confidential, high level outputs are not, and even some of the confidential aspects may be available to provide background guidance for policy. If you think this may be of value to your deliberations, I'm happy to walk anyone who is interested through it, and provide output data as and when I can ... Best wishes [REDACTED]